Suraksha Diagnostic Limited — Updates, 04-07-2025: Press Release

Suraksha Diagnostic has announced a board meeting to review the financial results for the quarter and half-year. The company launched Eastern India’s largest state-of-the-art genomics lab, investing ₹22 Cr with an additional ₹46 Cr planned over 24 months. The lab offers advanced genetic tests including fetal, hereditary cancer, and precision oncology panels, positioning Suraksha as a pioneer in genomics-driven diagnostics in the region. Post-IPO, raising ₹846.25 Cr, Suraksha is focused on expanding high-end diagnostics and personalized healthcare solutions across Eastern and North-Eastern India.